Detalhe da pesquisa
1.
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer.
Br J Cancer
; 129(1): 38-45, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37120671
2.
MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic.
Future Oncol
; 17(12): 1449-1458, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423550
3.
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer.
Clin Cancer Res
; 29(2): 331-340, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36378548
4.
Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers.
Curr Med Res Opin
; 25(10): 2423-8, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19663688